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Introduction {#jdi12094-sec-0001}
============

Insulin is the exclusive hormone that lowers plasma glucose concentration, and glucose homeostasis is maintained primarily as a result of regulated insulin secretion. Pancreatic β‐cells recognize extracellular glucose concentration and secrete insulin as required at a given time. Glucose‐stimulated insulin secretion (GSIS) is modulated by a number of factors, such as non‐glucose nutrients, hormones and neural inputs (Figure [1](#jdi12094-fig-0001){ref-type="fig"}). Thus, the intracellular network for regulation of insulin secretion is complex and multifactorial. Although GSIS has been viewed as analogous to excitation‐contraction coupling of muscle[1](#jdi12094-bib-0001){ref-type="ref"} and stimulus‐secretion coupling of neuron/chromaffin cells[2](#jdi12094-bib-0002){ref-type="ref"}, the regulatory system for GSIS is far more complex than these other two systems. In addition, the time frames of insulin secretion and neurotransmitter release are different: insulin secretion is tuned over minutes to hours, whereas neurotransmitter release occurs instantaneously; that is, within the subsecond range. As a counterpart for excitation‐contraction coupling and stimulus‐secretion coupling, Wollheim[3](#jdi12094-bib-0003){ref-type="ref"} coined the term 'metabolism‐secretion coupling' for GSIS, which will form the basis of the present review. We present an overview of existing concepts and models for GSIS, and provide a newer perspective based on recent developments in this field toward its physiological understanding. Although evidence for a 'glucose receptor' has recently been reported[4](#jdi12094-bib-0004){ref-type="ref"}, this topic will not be discussed in the present review, because its physiological relevance remains to be determined.

![A proposed signaling network of insulin exocytosis in pancreatic β‐cells. AC, adenylate cyclase; ATP, adenosine triphosphate; cAMP, cyclic adenosine monophosphate; GIP, glucose‐dependent insulinotropic peptide; GLP‐1, glucagon‐like polypeptide‐1; Glut, glucose transporter; K~ATP~ channel, adenosine triphosphate‐sensitive K^+^ channel; Kir6.2, K^+^ channel 6.2 subunits; LVDCC, L‐type voltage‐dependent calcium channel PACAP, pituitary adenylate cyclase activating peptide; PDH, pyruvate dehydrogenase; PC, pyruvate carboxylase; PKC, protein kinase C; PLC, phospholipase C; SUR1, sulfonylurea receptor 1.](jdi-4-511-g1){#jdi12094-fig-0001}

Adenosine Triphosphate‐Sensitive Potassium Channel: The Central Dogma {#jdi12094-sec-0002}
=====================================================================

On elevation of plasma glucose concentration, glucose enters the pancreatic β‐cells through the glucose transporter on the plasma membrane. Glucose is then phosphorylated by glucokinase and subjected to glycolysis, by which pyruvate is generated in the cytoplasm. Pyruvate is metabolized equally by pyruvate dehydrogenase and pyruvate carboxylase (PC) in the β‐cells, and passes into the mitochondria. The former reaction leads to generation of adenosine triphosphate (ATP) in the respiratory chain and the latter is accompanied by efflux of tricarboxylic acid (TCA) cycle intermediates as anaplerosis. ATP is a signaling molecule for insulin secretion in β‐cells, because the cell is equipped with ATP‐sensitive K^+^ channels (K~ATP~ channels), which close on elevation of cytoplasmic ATP or ATP/adenosine diphosphate ratio. As the K~ATP~ channel is the primary determinant of the membrane potential of the β‐cells, closure of these channels causes membrane depolarization. The membrane depolarization opens L‐type voltage‐dependent Ca^2+^ channels (VDCC), followed by Ca^2+^ influx and elevation of cytosolic free Ca^2+^ concentration (\[Ca^2+^\]~i~). The elevation of \[Ca^2+^\]~i~ rapidly increases the rate of insulin exocytosis.

This model has its origin in the pioneering work of Dean and Matthews[5](#jdi12094-bib-0005){ref-type="ref"}, and was formulated based on the nature of β‐cell electrophysiology[6](#jdi12094-bib-0006 jdi12094-bib-0007){ref-type="ref"}. Inagaki *et al*.[8](#jdi12094-bib-0008 jdi12094-bib-0009){ref-type="ref"} successfully identified the K~ATP~ channel in β‐cells as a tetra‐octamer composed of four sulfonylurea receptor 1 (SUR1) and inwardly rectifying K^+^ channel 6.2 subunits (Kir6.2). SUR1 is the target of insulin secretagogues, such as sulfonylurea (SU) and glinide used in the treatment of type 2 diabetes, such that the channel is closed on binding of SU or glinide to the SUR1. GSIS was completely abolished *in vitro* by treatment with diazoxide, a K~ATP~ channel opener, or nifedipine, a dihydropyridine Ca^2+^ channel blocker that inhibits opening of the VDCC. On the basis of these observations, signaling through K~ATP~ channels, VDCC and \[Ca^2+^\]~i~ elevation had been considered the exclusive mechanism underlying GSIS until 1992.

An acute elevation of \[Ca^2+^\]~i~ facilitates fusion of insulin granules and the plasma membrane leading to an increased rate of exocytosis. This reaction is mediated by the assembly of soluble *N*‐ethylmaleimide‐sensitive factor attachment protein receptor protein. However, the kinetics of exocytosis are considerably different between exocytosis of synaptic vesicles in neuronal cells and large dense‐core vesicles in β‐cells, with the former being more than five orders of magnitude faster than the latter[10](#jdi12094-bib-0010){ref-type="ref"}. In addition, glucose‐induced electrophysiological events; that is, K~ATP~ channel closure and elevation of \[Ca^2+^\]~i~, do not faithfully reflect the time‐course and concentration dependency of GSIS. These phenomena had been overlooked or left unanswered.

Biphasic Insulin Release and K~atp~ Channel‐Independent Glucose Action {#jdi12094-sec-0003}
======================================================================

In the early 1970s, Grodsky[11](#jdi12094-bib-0011){ref-type="ref"} established that GSIS is biphasic when extracellular glucose concentration is abruptly raised from sub‐ (3 mmol/L) to suprastimulatory concentrations (16.7--22.2 mmol/L). He suggested that glucose triggers insulin secretion from a threshold‐sensitive packet of insulin in the labile pool, and glucose potentiates insulin release by replenishing this labile pool by distinct mechanism(s). The first phase culminates 5--6 min after stimulation, and a gradual increase in insulin release over 60 min ensues, which is called the second phase[11](#jdi12094-bib-0011){ref-type="ref"}.

The temporal profile of the ionic events after glucose stimulation is significantly different from that of GSIS: glucose‐induced membrane depolarization and \[Ca^2+^\]~i~ rise are continuously oscillating, and by no means biphasic. The biphasic nature of GSIS is robust in rat and human islets, weak in mouse islets, and absent in most tumor β‐cell lines. A square wave application of a depolarizing concentration of K^+^ sharply increases the rate of insulin exocytosis for several minutes, which temporarily resembles the first phase[12](#jdi12094-bib-0012){ref-type="ref"}. However, in contrast to the insulin response to high glucose, high K^+^‐induced insulin release is monophasic and followed by gradual lowering; that is, there is no second phase. Nevertheless, the time‐courses of membrane depolarization and \[Ca^2+^\]~i~ elevation seen after K^+^ depolarization are similar, if not identical, to those induced by high glucose. These observations indicated that high glucose produces signal(s) for insulin secretion in addition to elevation of \[Ca^2+^\]~i~.

In 1992, the present authors and another group showed that glucose augments insulin exocytosis evoked by K^+^ depolarization even when the K~ATP~ channels are fully open or closed by the presence of diazoxide or SU, respectively[13](#jdi12094-bib-0013 jdi12094-bib-0014){ref-type="ref"}. In the presence of a high concentration of SU with the K~ATP~ channels fully closed, glucose induces an increase, not a decrease, in 86Rb^+^ outflow from the islet cells, which is a surrogate index of K^+^ outflow[15](#jdi12094-bib-0015){ref-type="ref"}. Importantly, GSIS in the presence of a depolarizing concentration of K^+^ and diazoxide occurs without any further increase in \[Ca^2+^\]~i~[16](#jdi12094-bib-0016){ref-type="ref"}. Thus, K~ATP~‐independent GSIS was established.

It has long been considered that there are distinct pools of insulin granules in the β‐cells, known as readily releasable pools (RRP) and reserve pools (RP)[17](#jdi12094-bib-0017){ref-type="ref"}. RRP is not necessarily physically docked to the plasma membrane. The biphasic GSIS has been understood as a product of a combination of triggering and amplification/augmentation along with this concept. That is, triggering denotes the initial rapid insulin exocytosis from the RRP by the K~ATP~‐dependent mechanism, and amplification/augmentation indicates gradual enhancement by the K~ATP~‐independent signal. The latter can occur with replenishment of the RRP from the RP, so we proposed viewing the biphasic insulin release as 'fusion and replenishment'[18](#jdi12094-bib-0018){ref-type="ref"}.

The aforementioned series of secretory and ionic events are observed on sudden increase in glucose from sub‐ to suprastimulatory concentration in the absence of any other stimuli, and so the conditions are markedly different from those seen physiologically.

Metabolic Amplification Factor {#jdi12094-sec-0004}
==============================

Although the molecule(s) responsible for the K~ATP~‐independent GSIS have yet to be identified, anaplerotic metabolism of pyruvate by PC and subsequent efflux of the TCA cycle intermediates are considered key events (Figure [1](#jdi12094-fig-0001){ref-type="fig"})[19](#jdi12094-bib-0019 jdi12094-bib-0020){ref-type="ref"}. The candidate molecules suggested to date as possible mediators of the K~ATP~ channel‐independent glucose action include ATP, guanosine 5′‐triphosphate, the reduced form of nicotinamide‐adenine dinucleotide, glutamate, malonyl‐CoA and Rab27a[21](#jdi12094-bib-0021 jdi12094-bib-0022){ref-type="ref"}. It is possible that thermosensitive transient receptor potential channel and Kv channels are involved in K~ATP~‐independent glucose signaling[23](#jdi12094-bib-0023 jdi12094-bib-0024){ref-type="ref"}.

Priming of β‐Cells {#jdi12094-sec-0005}
==================

Time‐Dependent Potentiation {#jdi12094-sec-0006}
---------------------------

Glucose causes time‐dependent potentiation (TDP) of insulin secretion; that is, exposure of islet β‐cells to high glucose enhances insulin release in response to the stimulus applied later[25](#jdi12094-bib-0025){ref-type="ref"}. Metabolizable amino acids and the glycolytic intermediate, glyceraldehyde, show similar enhancement of insulin secretion. In contrast, non‐metabolizable secretagogues, such as SU and high K^+^, do not prime the β‐cells in this manner. In contrast, metabolic inhibition abolishes TDP by glucose and the amino acids. Therefore, metabolic stimulus, the mitochondrial intermediates in the case of amino acids, is required for TDP. Interestingly, pharmacological activation of protein kinase C by phorbol ester also time‐dependently potentiates insulin secretion[26](#jdi12094-bib-0026){ref-type="ref"}.

The β‐cell priming by glucose occurs in a K~ATP~ channel‐independent manner, because the potentiation was totally resistant to a high concentration of diazoxide, an opener of K~ATP~ channels[12](#jdi12094-bib-0012){ref-type="ref"}. Furthermore, TDP occurs under stringent Ca^2+^‐free conditions and therefore \[Ca^2+^\]~i~ elevation is not required[27](#jdi12094-bib-0027){ref-type="ref"}. Taken together, these observations suggest that the second phase observed under a square wave high‐glucose application is the triggered insulin release followed by enhancement by TDP.

Permissive Role of Hormones, Non‐Glucose Fuels and Neural Inputs {#jdi12094-sec-0007}
----------------------------------------------------------------

### Incretins {#jdi12094-sec-0008}

Glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide are gastrointestinal hormones called incretins, which robustly enhance nutrient‐induced insulin secretion, and they are very important in the physiology of insulin secretion. Incretins bind to G protein‐coupled receptors on the β‐cell membrane and increase cellular 3′,5′‐cyclic adenosine monophosphate (cAMP). When the β‐cells are exposed to a stimulatory concentration of glucose, cAMP further elevates GSIS. Incretin action is resistant to diazoxide, and therefore it is independent of K~ATP~ channel closure[28](#jdi12094-bib-0028){ref-type="ref"}. cAMP enhances GSIS through protein kinase A (PKA)‐dependent and ‐independent mechanisms[29](#jdi12094-bib-0029){ref-type="ref"}. As one of the latter mechanisms, activation of the Epac2/Rap1 signaling cascade was proposed[30](#jdi12094-bib-0030){ref-type="ref"}. With regard to the insulin granule dynamics, cAMP increases the size of RRP in a glucose concentration‐dependent manner. This finding strongly indicates that incretin primes the β‐cells in the presence of stimulatory ambient glucose concentration. Incretin priming occurs in a Ca^2+^‐independent manner, even under stringent Ca^2+^‐free conditions[31](#jdi12094-bib-0031){ref-type="ref"}.

### Free Fatty Acid {#jdi12094-sec-0009}

Free fatty acid (FFA) participates in the regulation of GSIS. Insulin secretion is suppressed with long‐term exposure of β‐cells to excessively high concentration of FFA, which is called lipotoxicity[32](#jdi12094-bib-0032){ref-type="ref"}. However, short‐term (hours) exposure to the physiological concentration of FFA causes TDP[33](#jdi12094-bib-0033 jdi12094-bib-0034){ref-type="ref"}. The action of FFA appears to be mediated by FFA oxidation per se or accumulation of long chain acyl‐CoA in the cytoplasm. The insulinotropic action of FFA might be partially mediated by membrane receptor(s) for FFA, which is called GPR40 (Figure [1](#jdi12094-fig-0001){ref-type="fig"})[35](#jdi12094-bib-0035){ref-type="ref"}. An agonist of GPR40 that is currently in clinical trials[36](#jdi12094-bib-0036){ref-type="ref"} elevates \[Ca^2+^\]~i~ through activation of phospholipase C and protein kinase D1[37](#jdi12094-bib-0037){ref-type="ref"}. At any rate, FFA augmentation of GSIS is also independent of K~ATP~ channel[33](#jdi12094-bib-0033 jdi12094-bib-0034){ref-type="ref"}.

### Parasympathetic Nerves and Neuropeptides {#jdi12094-sec-0010}

Activation of the parasympathetic nervous system causes release of acetylcholine in the islets, and binding of acetylcholine to the membrane receptor leads to hydrolysis of phospholipids, accumulation of cellular inositol 1, 4, 5‐triphosphate and activation of PKC[38](#jdi12094-bib-0038){ref-type="ref"}. As a result, GSIS is strongly enhanced. This pathway might play a role in the cephalic phase of insulin release[39](#jdi12094-bib-0039){ref-type="ref"} and TDP (as aforementioned). Pituitary adenylate cyclase‐activating polypeptide (PACAP), which is located in the nerve endings around pancreatic islets, binds to its receptor on β‐cells and enhances insulin secretion at the picomolar range by increasing cellular cAMP[40](#jdi12094-bib-0040){ref-type="ref"}. Although the physiological significance of PACAP in controlling insulin secretion is still controversial, it is interesting that PACAP is one of the substrates for dipeptidyl‐peptidase 4.

Inhibitory Signals for Insulin Secretion {#jdi12094-sec-0011}
----------------------------------------

An important aspect of the physiological control of insulin secretion is the presence of inhibitory signals[41](#jdi12094-bib-0041){ref-type="ref"}. Heightened sympathetic tone suppresses insulin secretion through an increase in noradrenaline[42](#jdi12094-bib-0042){ref-type="ref"}. Noradrenaline binds to the α~2~‐adrenergic receptor and activates the heterotrimeric G protein. Somatostatin, which is secreted from pancreatic δ‐cells, suppresses insulin secretion by binding to the specific heterotrimeric G protein‐coupled receptor as well. These inhibitory hormones activate Gi and/or Go, and inhibit insulin exocytosis at multiple sites. It is likely that changes in the inhibitory signals are intimately involved in the physiology of insulin secretion *in vivo*.

Toward a Physiological Understanding {#jdi12094-sec-0012}
====================================

In the body, the β‐cells are primed by glucose, incretins, FFA and parasympathetic neural input, even under fasting conditions, because fasting plasma concentrations of glucose, active GLP‐1, and FFA are 5 mmol/L, 10 pmol/L and 500 μEq/L, respectively, which are within the stimulatory ranges for β‐cells. On intake of a meal, gradual elevation of glucose and amino acids occurs, and incretins and the parasympathetic input further increase. Concomitant suppression of sympathetic nerve input might influence to increase in insulin secretion.

Role of K~ATP~ Channels {#jdi12094-sec-0013}
-----------------------

SU and diazoxide, a closer and opener of K~ATP~ channels, enhance and reduce meal‐induced insulin secretion, respectively. The absence of K~ATP~ channels; that is, persistent closure, causes persistent hyperinsulinemic hypoglycemia, and activating mutation of the channel causes impaired insulin secretion and diabetes. Taken together, these observations imply that GSIS is affected by K~ATP~ channel closing and opening *in vivo*.

K~ATP~‐Independent GSIS {#jdi12094-sec-0014}
-----------------------

Robust insulin secretion in response to the intravenous bolus injection of glucose occurs in patients with loss of function SUR1 mutation, provided euglycemia has been maintained for hours by continuous glucose infusion[43](#jdi12094-bib-0043){ref-type="ref"}. This *in vivo* observation was supported by experimental data showing rapid insulin secretion in response to a square wave application of glucose by the islets from such patients or K~ATP~ channel knockout mice[44](#jdi12094-bib-0044 jdi12094-bib-0045){ref-type="ref"}. It is also important to recognize that the β‐cells from patients with persistent hyperinsulinemic hypoglycemia of infancy (PHHI) or K~ATP~ channel knockout mice do not secrete excess insulin *in vitro* with substimulatory concentration of glucose despite persistent elevation of \[Ca^2+^\]~i~[46](#jdi12094-bib-0046 jdi12094-bib-0047){ref-type="ref"}. Under these conditions, β‐cell \[Ca^2+^\]~i~ is elevated, but there are no other stimuli/priming, such as incretin/cAMP elevation, FFA and parasympathetic input/PKC activation. We hypothesize that GSIS occurs in the islet β‐cells, even in the absence of glucose regulation of K~ATP~ channels *in vivo* under priming with cAMP, non‐glucose nutrients and PKC. GSIS in PHHI patients after partial pancreatectomy provides further support for this hypothesis. The patients maintain non‐diabetic glycemia for years, and oral GSIS and meal‐stimulated insulin secretion do occur in them[48](#jdi12094-bib-0048){ref-type="ref"}. Post‐challenge incretin secretion would significantly assist GSIS on oral glucose or meal intake.

Additional experimental evidence for the hypothesis is as follows. Glucose increases insulin secretion by the islets, even under stringently Ca^2+^‐free conditions, given pre‐exposure of the islets to forskolin and phorbol ester, activators of PKA and PKC, respectively[49](#jdi12094-bib-0049){ref-type="ref"}. Recently, we showed rapid insulin secretion in islets pre‐exposed to forskolin on exposure to square wave high glucose in the presence of diazoxide and nifedipine[50](#jdi12094-bib-0050){ref-type="ref"}.

cAMP enhancement of GSIS has attracted renewed interest with the development of incretin mimetics for clinical use. Although detailed discussion of this topic is beyond the scope of the present review, it occurs only when ambient glucose concentration exceeds a threshold and is resistant to diazoxide, and so is a manifestation of K~ATP~‐independent GSIS[28](#jdi12094-bib-0028){ref-type="ref"}.

Summary {#jdi12094-sec-0015}
=======

Insulin secretion *in vivo* is finely tuned by a variety of stimulatory and inhibitory signals. It is important to appreciate that the β‐cells are being tonically primed with nutrients, and hormonal and neural inputs, even in the fasting state (Figure [2](#jdi12094-fig-0002){ref-type="fig"}). Meal intake produces gradual rather than instantaneous elevation of glucose. Thus, to gain a comprehensive understanding of the physiology of GSIS, careful experimentation and integration of accumulated knowledge are required. Further studies are needed to fully understand the complex and multifactorial mechanisms involved in GSIS.

![Distinction of glucose‐stimulated insulin release in (a) *in vitro* and (b) *in vivo*. (a) Square‐wave application of high glucose produces biphasic insulin release *in vitro*. Adenosine triphosphate‐sensitive K^+^ channel (K~ATP~ channel) closure is mandatory for this response. Nevertheless, glucose gradually enhances the Ca^2+^‐stimulated secretion in a K~ATP~ channel‐independent manner. (b) Under the physiological condition, the β‐cells are being continuously primed. Namely, the plasma level of glucose and other nutrients is at the weakly stimulatory range, and hormonal and neural stimuli are also present, even at fasting. A gradual elevation of plasma glucose after a meal robustly raises the rate of insulin exocytosis adenosine triphosphate‐sensitive K^+^ channel‐independently under this condition. ![](jdi-4-511-gr1.jpg "image"), Constitutive secretion; ![](jdi-4-511-gr2.jpg "image"), K^+^ channel‐dependent secretion; ![](jdi-4-511-gr3.jpg "image"), K^+^ channel‐independent secretion.](jdi-4-511-g2){#jdi12094-fig-0002}
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